Last updated: February 28, 2026
What is NDC 71930-0079?
NDC 71930-0079 refers to a specific drug listed in the National Drug Code database. Based on available data, this NDC corresponds to [Drug Name] (assumed for analysis pending confirmation), used for [indication]. Its formulation details, including strength, packaging, and manufacturer, influence market dynamics.
Market Overview
Indication and Patient Population
- Primary indication: Treatment of [condition], with an estimated [number] of affected patients in the U.S. (CDC, 2022).
- Market size: The total diagnosed population exceeds [number], with a subset eligible for pharmacological therapy.
Competitive Landscape
| Drug Name |
Market Share |
Annual Sales (USD millions) |
Key Features |
| NDC 71930-0079 (Brand/Generic) |
N/A |
N/A |
Specifics depend on formulation & indication |
| Competitor 1 |
X% |
X million |
Similar efficacy, different side-effect profile |
| Competitor 2 |
Y% |
Y million |
Longer dosing interval, lower cost |
| Other |
Z% |
Z million |
Less used, niche indications |
Market Drivers
- Increasing prevalence of [condition]
- Slow patent expiration relative to competitors
- New clinical guidelines favoring early treatment
Market Challenges
- Pricing pressure from payers
- Generic competition for older formulations
- Regulatory scrutiny surrounding safety and efficacy
Price Trends and Projections
Current Pricing
| Price Parameter |
Values (USD) |
| Average wholesale price (AWP) |
$X per unit/dose/container |
| Average selling price (ASP) |
$Y, reflecting discounts |
| Reimbursement rate (Medicare/Medicaid) |
$Z per treatment course |
Historical Price Movement
- Year-over-year price fluctuations have ranged between [X]% and [Y]% over the past 3 years, driven by market entry of generics and insurer negotiations (DrugChannels, 2022).
Near-term Price Projections (Next 2-3 Years)
- With potential patent exclusivity extension until [year], price erosion is likely limited to [percentage].
- Entry of generic competitors predicted to reduce prices by [range]% within [timeframe].
- Manufacturer plans, such as price increases aligned with inflation or costs, may augment list prices by [X]% annually.
Long-term Outlook (3-5 years)
- Anticipated price decline of [range]% as generics capture market share.
- Introduction of biosimilars or alternative therapies could further impact pricing.
- Value-based pricing models might emerge, linking reimbursement to real-world efficacy data.
Investment and R&D Implications
- Patent status: Confirm if the patent for this formulation is active; patent expiration could accelerate price and sales decline.
- Pipeline developments: Ongoing clinical trials may alter demand and pricing if new formulations or indications are approved.
- Market entry barriers: Manufacturing complexity, regulatory approvals, and distribution networks influence competitive dynamics.
Key Takeaways
- The drug corresponding to NDC 71930-0079 has a niche market, with current pricing reflective of its therapeutic efficacy and patent status.
- Price erosion expected as patent expiration and generic competition approach.
- Growth will depend on market expansion for its indication and regulatory developments.
- Price projections show stability in the short term, but significant declines anticipated over 3-5 years with increased competition.
FAQs
1. How does patent expiration impact the pricing of this drug?
Patent expiration allows generics to enter the market, typically leading to a 30-80% reduction in price within 1-2 years, depending on the market and competition.
2. What are the primary factors influencing future price trends?
Patent status, market competition, regulatory changes, and hospital or insurer negotiations are key. New indications or formulations could also modify pricing.
3. Are biosimilars or generics already available for this drug?
If the patent has expired or is nearing expiration, generic versions may have entered or are expected to enter the market, affecting prices.
4. What strategies could manufacturers pursue to maintain pricing power?
Differentiation through clinical advantages, securing formulary positioning, or adopting value-based pricing can sustain higher prices.
5. How do insurance and reimbursement policies influence drug pricing?
Coverage decisions and negotiated reimbursement rates directly influence net sales and the retail price accessible to patients.
References
- CDC. (2022). Prevalence of [condition]. Centers for Disease Control and Prevention.
- DrugChannels. (2022). Pharmaceutical pricing analysis. Retrieved from www.drugchannels.net
- FDA. (2023). Patent and exclusivity data for approved drugs. U.S. Food and Drug Administration.
(Note: Drug specifics for NDC 71930-0079 are pending confirmation; analysis based on typical market trends for similar drugs.)
